Abstract
Sprouty2 (SPRY2) is a potent negative regulator of receptor tyrosine kinase signaling, and is implicated as a tumor suppressor. SPRY2 inhibits FGF–RAS–ERK signaling by binding to growth factor receptor bound protein 2 (GRB2) during fibroblast growth factor receptor (FGFR) activation, disrupting the GRB2–SOS (son of sevenless) complex that transduces signals from FGFR to RAS. SPRY2 binding to GRB2 is modulated by phosphorylation but the key regulatory kinase(s) are not known. Prior studies identified the frequent presence of CK1 phosphorylation motifs on SPRY2. We therefore tested if CK1 has a role in SPRY2 phosphorylation and function. Loss of CK1 binding and inhibition of CK1 activity by two structurally distinct small molecules abrogated SPRY2 inhibition of FGF–ERK signaling, leading to decreased SPRY2 interaction with GRB2. Moreover, CK1 activity and binding are necessary for SPRY2 inhibition of FGF-stimulated neurite outgrowth in PC12 cells. Consistent with its proposed role as an inhibitor of FGF signaling, we find that CSNK1E transcript abundance negatively correlates with FGF1/FGF7 message in human gastric cancer samples. Modulation of CK1 activity may be therapeutically useful in the treatment of FGF/SPRY2-related diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lemmon MA, Schlessinger J . Cell signaling by receptor tyrosine kinases. Cell 2010; 141: 1117–1134.
Casaletto JB, McClatchey AI . Spatial regulation of receptor tyrosine kinases in development and cancer. Nat Rev Cancer 2012; 12: 387–400.
Casci T, Vinos J, Freeman M . Sprouty an intracellular inhibitor of Ras signaling. Cell 1999; 96: 655–665.
Impagnatiello MA, Weitzer S, Gannon G, Compagni A, Cotten M, Christofori G . Mammalian sprouty-1 and -2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells. J Cell Biol 2001; 152: 1087–1098.
Yusoff P, Lao DH, Ong SH, Wong ES, Lim J, Lo TL et al. Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf. J Biol Chem 2002; 277: 3195–3201.
Wong ES, Fong CW, Lim J, Yusoff P, Low BC, Langdon WY et al. Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling. EMBO J 2002; 21: 4796–4808.
Hausott B, Vallant N, Auer M, Yang L, Dai F, Brand-Saberi B et al. Sprouty2 down-regulation promotes axon growth by adult sensory neurons. Mol Cell Neurosci 2009; 42: 328–340.
Hacohen N, Kramer S, Sutherland D, Hiromi Y, Krasnow MA . sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell 1998; 92: 253–263.
Metzger RJ, Klein OD, Martin GR, Krasnow MA . The branching programme of mouse lung development. Nature 2008; 453: 745–750.
Tang N, Marshall WF, McMahon M, Metzger RJ, Martin GR . Control of mitotic spindle angle by the RAS-regulated ERK1/2 pathway determines lung tube shape. Science 2011; 333: 342–345.
Lo TL, Yusoff P, Fong CW, Guo K, McCaw BJ, Phillips WA et al. The ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer. Cancer Res 2004; 64: 6127–6136.
Fong CW, Chua MS, McKie AB, Ling SH, Mason V, Li R et al. Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma. Cancer Res 2006; 66: 2048–2058.
Patel R, Gao M, Ahmad I, Fleming J, Singh LB, Rai TS et al. Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression. J Clin Invest 2013; 123: 1157–1175.
Edwin F, Anderson K, Ying C, Patel TB . Intermolecular interactions of Sprouty proteins and their implications in development and disease. Mol Pharmacol 2009; 76: 679–691.
Guy GR, Jackson RA, Yusoff P, Chow SY . Sprouty proteins: modified modulators, matchmakers or missing links? J Endocrinol 2009; 203: 191–202.
Turner N, Grose R . Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 2010; 10: 116–129.
Lao DH, Chandramouli S, Yusoff P, Fong CW, Saw TY, Tai LP et al. A Src homology 3-binding sequence on the C terminus of Sprouty2 is necessary for inhibition of the Ras/ERK pathway downstream of fibroblast growth factor receptor stimulation. J Biol Chem 2006; 281: 29993–30000.
Hanafusa H, Torii S, Yasunaga T, Nishida E . Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nat Cell Biol 2002; 4: 850–858.
Lao DH, Yusoff P, Chandramouli S, Philp RJ, Fong CW, Jackson RA et al. Direct binding of PP2A to Sprouty2 and phosphorylation changes are a prerequisite for ERK inhibition downstream of fibroblast growth factor receptor stimulation. J Biol Chem 2007; 282: 9117–9126.
DaSilva J, Xu L, Kim HJ, Miller WT, Bar-Sagi D . Regulation of sprouty stability by Mnk1-dependent phosphorylation. Mol Cell Biol 2006; 26: 1898–1907.
Chandramouli S, Yu CY, Yusoff P, Lao DH, Leong HF, Mizuno K et al. Tesk1 interacts with Spry2 to abrogate its inhibition of ERK phosphorylation downstream of receptor tyrosine kinase signaling. J Biol Chem 2008; 283: 1679–1691.
Aranda S, Alvarez M, Turro S, Laguna A, de la Luna S . Sprouty2-mediated inhibition of fibroblast growth factor signaling is modulated by the protein kinase DYRK1A. Mol Cell Biol 2008; 28: 5899–5911.
Flotow H, Graves PR, Wang AQ, Fiol CJ, Roeske RW, Roach PJ . Phosphate groups as substrate determinants for casein kinase I action. J Biol Chem 1990; 265: 14264–14269.
Cegielska A, Virshup DM . Control of simian virus 40 DNA replication by the HeLa cell nuclear kinase casein kinase I. Mol Cell Biol 1993; 13: 1202–1211.
Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM et al. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 2001; 291: 1040–1043.
Rubinfeld B, Tice DA, Polakis P . Axin-dependent phosphorylation of the adenomatous polyposis coli protein mediated by casein kinase 1epsilon. J Biol Chem 2001; 276: 39037–39045.
Okamura H, Garcia-Rodriguez C, Martinson H, Qin J, Virshup DM, Rao A . A conserved docking motif for CK1 binding controls the nuclear localization of NFAT1. Mol Cell Biol 2004; 24: 4184–4195.
Badura L, Swanson T, Adamowicz W, Adams J, Cianfrogna J, Fisher K et al. An inhibitor of casein kinase I epsilon induces phase delays in circadian rhythms under free-running and entrained conditions. J Pharmacol Exp Ther 2007; 322: 730–738.
Cheong JK, Nguyen TH, Wang H, Tan P, Voorhoeve PM, Lee SH et al. IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1delta/varepsilon and Wnt/beta-catenin independent inhibition of mitotic spindle formation. Oncogene 2011; 30: 2558–2569.
Amit S, Hatzubai A, Birman Y, Andersen JS, Ben-Shushan E, Mann M et al. Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev 2002; 16: 1066–1076.
Lord C, Bhandari D, Menon S, Ghassemian M, Nycz D, Hay J et al. Sequential interactions with Sec23 control the direction of vesicle traffic. Nature 2011; 473: 181–186.
Rena G, Bain J, Elliott M, Cohen P . D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a. EMBO Rep 2004; 5: 60–65.
Lim J, Yusoff P, Wong ES, Chandramouli S, Lao DH, Fong CW et al. The cysteine-rich sprouty translocation domain targets mitogen-activated protein kinase inhibitory proteins to phosphatidylinositol 4,5-bisphosphate in plasma membranes. Mol Cell Biol 2002; 22: 7953–7966.
Lim J, Wong ES, Ong SH, Yusoff P, Low BC, Guy GR . Sprouty proteins are targeted to membrane ruffles upon growth factor receptor tyrosine kinase activation. Identification of a novel translocation domain. J Biol Chem 2000; 275: 32837–32845.
Gross I, Armant O, Benosman S, de Aguilar JL, Freund JN, Kedinger M et al. Sprouty2 inhibits BDNF-induced signaling and modulates neuronal differentiation and survival. Cell Death Differ 2007; 14: 1802–1812.
Greer YE, Rubin JS . Casein kinase 1 delta functions at the centrosome to mediate Wnt-3a-dependent neurite outgrowth. J Cell Biol 2011; 192: 993–1004.
Birrer MJ, Johnson ME, Hao K, Wong KK, Park DC, Bell A et al. Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas. J Clin Oncol 2007; 25: 2281–2287.
Smith G, Ng MT, Shepherd L, Herrington CS, Gourley C, Ferguson MJ et al. Individuality in FGF1 expression significantly influences platinum resistance and progression-free survival in ovarian cancer. Br J Cancer 2012; 107: 1327–1336.
Nakazawa K, Yashiro M, Hirakawa K . Keratinocyte growth factor produced by gastric fibroblasts specifically stimulates proliferation of cancer cells from scirrhous gastric carcinoma. Cancer Res 2003; 63: 8848–8852.
Toyokawa T, Yashiro M, Hirakawa K . Co-expression of keratinocyte growth factor and K-sam is an independent prognostic factor in gastric carcinoma. Oncol Rep 2009; 21: 875–880.
Ooi CH, Ivanova T, Wu J, Lee M, Tan IB, Tao J et al. Oncogenic pathway combinations predict clinical prognosis in gastric cancer. PLoS Genet 2009; 5: e1000676.
Lei Z, Tan IB, Das K, Deng N, Zouridis H, Pattison S et al. Identification of molecular subtypes of gastric cancer with different responses to pi3-kinase inhibitors and 5-fluorouracil. Gastroenterology 2013; 145: 554–565.
Cheong JK, Virshup DM . Casein kinase 1: complexity in the family. Int J Biochem Cell Biol 2011; 43: 465–469.
Swiatek W, Tsai IC, Klimowski L, Pepler A, Barnette J, Yost HJ et al. Regulation of casein kinase I epsilon activity by Wnt signaling. J Biol Chem 2004; 279: 13011–13017.
Liu F, Virshup DM, Nairn AC, Greengard P . Mechanism of regulation of casein kinase I activity by group I metabotropic glutamate receptors. J Biol Chem 2002; 277: 45393–45399.
Pullar CE, Chen J, Isseroff RR . PP2A activation by beta2-adrenergic receptor agonists: novel regulatory mechanism of keratinocyte migration. J Biol Chem 2003; 278: 22555–22562.
Belch J, Hiatt WR, Baumgartner I, Driver IV, Nikol S, Norgren L et al. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet 2011; 377: 1929–1937.
Beenken A, Mohammadi M . The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov 2009; 8: 235–253.
Chow SY, Yu CY, Guy GR . Sprouty2 interacts with protein kinase C delta and disrupts phosphorylation of protein kinase D1. J Biol Chem 2009; 284: 19623–19636.
Tsai IC, Amack JD, Gao ZH, Band V, Yost HJ, Virshup DM . A Wnt-CKIvarepsilon-Rap1 pathway regulates gastrulation by modulating SIPA1L1, a Rap GTPase activating protein. Dev Cell 2007; 12: 335–347.
Meng QJ, Logunova L, Maywood ES, Gallego M, Lebiecki J, Brown TM et al. Setting clock speed in mammals: the CK1 epsilon tau mutation in mice accelerates circadian pacemakers by selectively destabilizing PERIOD proteins. Neuron 2008; 58: 78–88.
Wong ES, Lim J, Low BC, Chen Q, Guy GR . Evidence for direct interaction between Sprouty and Cbl. J Biol Chem 2001; 276: 5866–5875.
Acknowledgements
We thank Dr Permeen Yusoff and Dr Jit Kong Cheong for advice. This research was supported by the National Medical Research Council of Singapore under its STaR Award program to DMV, the A*STAR Graduate Scholarship (to DGRY) and by the Agency for Science, Technology and Research, Singapore.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Yim, D., Ghosh, S., Guy, G. et al. Casein kinase 1 regulates Sprouty2 in FGF–ERK signaling. Oncogene 34, 474–484 (2015). https://doi.org/10.1038/onc.2013.564
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2013.564
Keywords
This article is cited by
-
K63-linked ubiquitination of DYRK1A by TRAF2 alleviates Sprouty 2-mediated degradation of EGFR
Cell Death & Disease (2021)